MCID: RCR004
MIFTS: 40

Recurrent Respiratory Papillomatosis malady

Categories: Rare diseases, Respiratory diseases

Aliases & Classifications for Recurrent Respiratory Papillomatosis

About this section
Sources:
40MESH via Orphanet, 48NIH Rare Diseases, 54Orphanet, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Recurrent Respiratory Papillomatosis:

Name: Recurrent Respiratory Papillomatosis 48 54 68
Juvenile-Onset Recurrent Respiratory Papillomatosis 48
Adult-Onset Recurrent Respiratory Papillomatosis 48
Respiratory Papillomatosis, Recurrent 48
Laryngeal Papilloma, Recurrent 48
 
Juvenile Laryngeal Papilloma 48
Jorrp 48
Aorrp 48
Rrp 48

Characteristics:

Orphanet epidemiological data:

54
recurrent respiratory papillomatosis:
Age of onset: Adolescent,Adult,Childhood

Classifications:



External Ids:

Orphanet54 ORPHA60032
UMLS via Orphanet69 C1168198
MESH via Orphanet40 C535297

Summaries for Recurrent Respiratory Papillomatosis

About this section
NIH Rare Diseases:48 Recurrent respiratory papillomatosis (RRP) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). Although the tumors can grow anywhere in the respiratory tract, their presence in the larynx (voice box) causes the most frequent problems, a condition called laryngeal papillomatosis. The tumors may vary in size and grow very quickly. They often grow back even when removed. RRP is caused by two types of human papillomavirus (HPV), called HPV 6 and HPV 11. Last updated: 11/21/2011

MalaCards based summary: Recurrent Respiratory Papillomatosis, also known as juvenile-onset recurrent respiratory papillomatosis, is related to laryngeal papillomatosis and fruit allergy. An important gene associated with Recurrent Respiratory Papillomatosis is HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1), and among its related pathways are Staphylococcus aureus infection and CTLA4 Signaling. Affiliated tissues include lung, bone and t cells.

Related Diseases for Recurrent Respiratory Papillomatosis

About this section

Diseases related to Recurrent Respiratory Papillomatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 86)
idRelated DiseaseScoreTop Affiliating Genes
1laryngeal papillomatosis11.0
2fruit allergy10.4HLA-DQB1, HLA-DRB1
3wolffian duct adenocarcinoma10.4HLA-DQB1, HLA-DRB1
4quinquaud's decalvans folliculitis10.4HLA-DQB1, HLA-DRB1
5parsonage turner syndrome10.4HLA-DQB1, HLA-DRB1
6pediatric systemic lupus erythematosus10.4HLA-DQB1, HLA-DRB1
7myopathy-growth delay-intellectual disability-hypospadias syndrome10.4HLA-DQB1, HLA-DRB1
8krieble bixler syndrome10.4HLA-DQB1, HLA-DRB1
9spondylarthropathy10.4HLA-DQB1, HLA-DRB1
10mitochondrial encephalomyopathy10.4HLA-DQB1, HLA-DRB1
11rheumatic myocarditis10.4HLA-DQB1, HLA-DRB1
12ovarian papillary cystadenoma10.4HLA-DQB1, HLA-DRB1
13nebulin-related early-onset distal myopathy10.4HLA-DQB1, HLA-DRB1
14purpura fulminans10.4HLA-DQB1, HLA-DRB1
15lymphocytic colitis10.4HLA-DQB1, HLA-DRB1
16autoinflammation, lipodystrophy, and dermatosis syndrome10.4HLA-DQB1, HLA-DRB1
17peripheral t-cell lymphoma10.4HLA-DQB1, HLA-DRB1
18foster-kennedy syndrome10.4HLA-DQB1, HLA-DRB1
19thrombocytopenia due to platelet alloimmunization10.4HLA-DQB1, HLA-DRB1
20orbit alveolar rhabdomyosarcoma10.4HLA-DQB1, HLA-DRB1
21x-linked congenital generalized hypertrichosis10.4HLA-DQB1, HLA-DRB1
22anthracosilicosis10.4HLA-DRB1, IL2
23aseptic osteitis10.4HLA-DQB1, HLA-DRB1
24idiopathic central precocious puberty10.4HLA-DQB1, HLA-DRB1
25oculogyric crisis10.4HLA-DQB1, HLA-DRB1
26sensorineural hearing loss10.4HLA-DQB1, HLA-DRB1
27mononeuritis of upper limb10.4HLA-DQB1, HLA-DRB1
28multicentric castleman disease10.4HLA-DQB1, HLA-DRB1
29allergic hypersensitivity disease10.4HLA-DQB1, HLA-DRB1
30skin sarcoidosis10.4HLA-DRB1, IL2
31hypoxia10.4HLA-DQB1, HLA-DRB1
32cirrhotic cardiomyopathy10.3HLA-DQB1, HLA-DRB1
33epidermolysis bullosa simplex superficialis10.3HLA-DQB1, HLA-DRB1
34achilles bursitis10.3HLA-DQB1, HLA-DRB1
35respiratory system disease10.3HLA-DRB1, IL2
36renovascular hypertension10.3HLA-DRB1, IL2
37breast carcinoma in situ10.3HLA-DQB1, HLA-DRB1
38iridocyclitis10.3HLA-DRB1, IL2
39cervical benign neoplasm10.3EGFR, HLA-DRB1
40subcorneal pustular dermatosis10.3HLA-DQB1, HLA-DRB1
41subendocardial infarction acute myocardial infarction10.2HLA-DQB1, IL2
42hypertrophic or verrucous lupus erythematosus10.2HLA-DRB1, IFNA2
43hereditary conventional renal cell carcinoma10.2HLA-DRB1, IL2
44papilloma10.2
45kernicterus10.2HLA-DRB1, IL2
46childhood type dermatomyositis10.2EGFR, HLA-DRB1
47central gyrate choroidal dystrophy10.2HLA-DRB1, IFNA2
48early congenital syphilis10.2EGFR, IL2
49xanthomatosis10.2HLA-DRB1, IL2
50emphysema, congenital lobar10.1HLA-DRB1, IL2

Graphical network of the top 20 diseases related to Recurrent Respiratory Papillomatosis:



Diseases related to recurrent respiratory papillomatosis

Symptoms & Phenotypes for Recurrent Respiratory Papillomatosis

About this section

Drugs & Therapeutics for Recurrent Respiratory Papillomatosis

About this section

Drugs for Recurrent Respiratory Papillomatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CidofovirapprovedPhase 4, Phase 233113852-37-260613
Synonyms:
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
113852-37-2
120362-37-0 (hydrochloride salt)
149394-66-1
AC-1666
AC1L1TLB
AC1Q6C68
AKOS005145721
C8H14N3O6P
CDV
CHEBI:3696
 
CHEMBL152
CID60613
Cidofovir
Cidofovir (Vistide)
Cidofovir (anhydrous)
Cidofovir Anhydrous
Cidofovir anhydrous
Cidofovirum
DB00369
Forvade
GS 0504
GS 504
GS-0504
GS-504
GS504
HPMPC
HSDB 7115
LS-106432
MolPort-005-935-597
NSC742135
S1516_Selleck
UNII-768M1V522C
Vistide
Vistide, Cidofovir
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
2Anti-Infective AgentsPhase 4, Phase 221402
3Antiviral AgentsPhase 4, Phase 3, Phase 29732
4ImmunoglobulinsPhase 3, Phase 26045
5AntibodiesPhase 3, Phase 26045
6VaccinesPhase 3, Early Phase 16428
7
Bevacizumabapproved, investigationalPhase 2, Phase 11968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
8
Celecoxibapproved, investigationalPhase 2435169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
9
PembrolizumabapprovedPhase 24211374853-91-4
Synonyms:
Keytruda
 
MK-3475
lambrolizumab
10
Vitamin Aapproved, nutraceutical, vet_approvedPhase 246811103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
11Peripheral Nervous System AgentsPhase 222776
12Angiogenesis InhibitorsPhase 2, Phase 14143
13Cyclooxygenase InhibitorsPhase 22778
14Angiogenesis Modulating AgentsPhase 2, Phase 14072
15Analgesics, Non-NarcoticPhase 26260
16Cyclooxygenase 2 InhibitorsPhase 2616
17Anti-Inflammatory AgentsPhase 210355
18AnalgesicsPhase 211287
19Anti-Inflammatory Agents, Non-SteroidalPhase 24295
20Antirheumatic AgentsPhase 210627
21Pharmaceutical SolutionsPhase 27793
22Antibodies, MonoclonalPhase 23795
23Retinol palmitatePhase 2468
24retinolNutraceuticalPhase 2468
25
Ergocalciferolapproved, nutraceuticalPhase 1123250-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
26Trace ElementsPhase 15802
27vitamin dPhase 11653
28MicronutrientsPhase 15802
29Bone Density Conservation AgentsPhase 13266
30VitaminsPhase 15095
31ErgocalciferolsPhase 11232
32CalciferolNutraceuticalPhase 11334
33Vitamin D2NutraceuticalPhase 11232
34Pepsin A14

Interventional clinical trials:

(show all 20)
idNameStatusNCT IDPhase
1Use of Cidofovir for Recurrent Respiratory PapillomatosisCompletedNCT00205374Phase 4
2Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")TerminatedNCT00747461Phase 4
3Effect of Vaccination in Patients With Recurrent Respiratory PapillomatosisActive, not recruitingNCT01375868Phase 3
44-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in ChildrenNot yet recruitingNCT01995721Phase 3
5Propranolol Administration in Pediatric Patients With Recurrent Respiratory PapillomatosisWithdrawnNCT01058317Phase 2, Phase 3
6Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory PapillomatosisCompletedNCT00571701Phase 2
7A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory PapillomatosisCompletedNCT00038714Phase 2
8Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory PapillomatosisRecruitingNCT02555800Phase 2
9Avelumab for People With Recurrent Respiratory PapillomatosisRecruitingNCT02859454Phase 2
10Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary InvolvementRecruitingNCT02632344Phase 2
11New Therapy of Laryngeal Papilloma In ChildrenTerminatedNCT00591305Phase 2
12Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)CompletedNCT01020747Phase 1
13Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)Not yet recruitingNCT02854761Phase 1
14Optical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWithdrawnNCT00733252Phase 1
15Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRPCompletedNCT00550914
16Human Papillomatosis Genotyping of Children in ThailandCompletedNCT01304966
17Human Papillomavirus 6/11 in the Lower Airway of NeonatesCompletedNCT00549250
18Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous LesionsCompletedNCT02217358
19Recurrent Respiratory Papillomatosis and Extraesophageal RefluxRecruitingNCT02592902
20Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory PapillomatosisWithdrawnNCT00829608Early Phase 1

Search NIH Clinical Center for Recurrent Respiratory Papillomatosis

Genetic Tests for Recurrent Respiratory Papillomatosis

About this section

Anatomical Context for Recurrent Respiratory Papillomatosis

About this section

MalaCards organs/tissues related to Recurrent Respiratory Papillomatosis:

36
Lung, Bone, T cells, Testes, Trachea, Spinal cord

Publications for Recurrent Respiratory Papillomatosis

About this section

Articles related to Recurrent Respiratory Papillomatosis:

(show top 50)    (show all 368)
idTitleAuthorsYear
1
Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis (prospective case-control study). (27759910)
2016
2
Multidimensional vocal assessment after laser treatment for recurrent respiratory papillomatosis. (27515839)
2016
3
The association between gastroesophageal reflux disease and recurrent respiratory papillomatosis: A systematic review. (27113025)
2016
4
Response to letter to Editor: "The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors" by Michel R. M. San Giorgi et al. (27654254)
2016
5
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis. (27188508)
2016
6
Determination of the complete genome and functional analysis of HPV6 isolate VBD19/10 from a patient with aggressive recurrent respiratory papillomatosis. (26931553)
2016
7
Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates. (27074766)
2016
8
Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan. (26860235)
2016
9
Validation of the Distress Thermometer and Problem List in Patients with Recurrent Respiratory Papillomatosis. (27600632)
2016
10
Safety of paediatric day-stay laryngeal surgery for recurrent respiratory papillomatosis. (26857327)
2016
11
Prevalence and management of Recurrent Respiratory Papillomatosis (RRP) in the UK: cross sectional study. (27208548)
2016
12
Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report. (27863633)
2016
13
Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity. (27658005)
2016
14
Impaired T Cell-dependent Humoral Immune Response Associated with Juvenile-onset Recurrent Respiratory Papillomatosis Progression. (27821867)
2016
15
Is recurrent respiratory papillomatosis a manageable or curable disease? (26608928)
2016
16
Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis. (26968061)
2016
17
Quality of life of patients with recurrent respiratory papillomatosis. (27861969)
2016
18
Recurrent respiratory papillomatosis of the airway: The experience of an endoscopic unit. (25926371)
2015
19
Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis. (26151558)
2015
20
Viral load and mRNA expression of HPV type 6 among cases with recurrent respiratory papillomatosis. (26010342)
2015
21
Acoustical and Perceptual Voice Profiling of Children With Recurrent Respiratory Papillomatosis. (26474713)
2015
22
Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population. (26453486)
2015
23
Molecular subtypification of human papillomavirus in male adult individuals with recurrent respiratory papillomatosis. (25906915)
2015
24
Recurrent respiratory papillomatosis progressing into squamous cell carcinoma in an HIV-positive patient. (26153613)
2015
25
Recurrent respiratory papillomatosis in northern Sweden: clinical characteristics and practical guidance. (26004132)
2015
26
Nucleotide and phylogenetic analysis of human papillomavirus type 11 isolated from juvenile-onset recurrent respiratory papillomatosis in China. (26369639)
2015
27
Age of onset of Recurrent Respiratory Papillomatosis: a distribution analysis. (26460806)
2015
28
FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung. (26204210)
2015
29
Recurrent respiratory papillomatosis: current and future perspectives. (25999724)
2015
30
Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. (24964770)
2014
31
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. (25289079)
2014
32
Decreased Langerhans Cell Responses to IL-36I^: Altered Innate Immunity in Patients with Recurrent Respiratory Papillomatosis. (24950037)
2014
33
Photodynamic therapy for recurrent respiratory papillomatosis. (24898010)
2014
34
A Case of Recurrent Respiratory Papillomatosis Successfully Removed Via Endoscopic Argon Plasma Coagulation (APC) With No Evidence of Recurrence. (25500852)
2014
35
Pulmonary papillomatosis: a rare case of recurrent respiratory papillomatosis presenting with multiple nodular and cavitary lesions. (25348187)
2014
36
Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir. (25762828)
2014
37
Diagnosis and management of recurrent respiratory papillomatosis. (25229272)
2014
38
Malignant degeneration of pulmonary juvenile-onset recurrent respiratory papillomatosis. (25487719)
2014
39
Chromoendoscopy Associated With Endoscopic Laryngeal Surgery: A New Technique for Treating Recurrent Respiratory Papillomatosis. (24674651)
2014
40
Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. (24722383)
2014
41
The incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in the Free State province of South Africa and Lesotho. (25300480)
2014
42
Adult-Onset Recurrent Respiratory Papillomatosis: A Review of Disease Pathogenesis and Implications for Patient Counseling. (25393901)
2014
43
Voice and quality of life in patients with recurrent respiratory papillomatosis in a northern Sweden cohort. (24433057)
2014
44
The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors. (25351501)
2014
45
A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion. (24942884)
2014
46
Clinical course of recurrent respiratory papillomatosis: Comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. (24955561)
2014
47
Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis. (25391185)
2014
48
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis. (24756616)
2014
49
Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles. (25419846)
2014
50
Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia. (24918765)
2014

Variations for Recurrent Respiratory Papillomatosis

About this section

Expression for genes affiliated with Recurrent Respiratory Papillomatosis

About this section
Search GEO for disease gene expression data for Recurrent Respiratory Papillomatosis.

Pathways for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Pathways related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathwaysScoreTop Affiliating Genes
19.7HLA-DQB1, HLA-DRB1
29.7HLA-DQB1, HLA-DRB1
39.6HLA-DRB1, IL2
49.6HLA-DRB1, IL2
59.5EGFR, IL2
6
Show member pathways
9.2HLA-DQB1, HLA-DRB1, IL2
79.2HLA-DQB1, HLA-DRB1, IL2
8
Show member pathways
9.2HLA-DQB1, HLA-DRB1, IL2
99.2EGFR, HLA-DQB1, HLA-DRB1
109.1HLA-DQB1, HLA-DRB1, IFNA2
11
Show member pathways
9.1HLA-DQB1, HLA-DRB1, IFNA2
128.9EGFR, IFNA2, IL2
138.9EGFR, IFNA2, IL2
14
Show member pathways
8.7EGFR, HLA-DQB1, HLA-DRB1, IL2
15
Show member pathways
8.6HLA-DQB1, HLA-DRB1, IFNA2, IL2
16
Show member pathways
8.6IFNA2, IL2, KIR2DL2
17
Show member pathways
7.8HLA-DQB1, HLA-DRB1, IFNA2, IL2, KIR2DL2
18
Show member pathways
7.3EGFR, HLA-DQB1, HLA-DRB1, IFNA2, IL2, KIR2DL2

GO Terms for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Cellular components related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1clathrin-coated endocytic vesicle membraneGO:003066910.4HLA-DQB1, HLA-DRB1
2endocytic vesicle membraneGO:003066610.4HLA-DQB1, HLA-DRB1
3ER to Golgi transport vesicle membraneGO:001250710.4HLA-DQB1, HLA-DRB1
4integral component of lumenal side of endoplasmic reticulum membraneGO:007155610.2HLA-DQB1, HLA-DRB1
5MHC class II protein complexGO:004261310.1HLA-DQB1, HLA-DRB1
6transport vesicle membraneGO:00306589.7HLA-DQB1, HLA-DRB1
7Golgi membraneGO:00001399.2EGFR, FUT8, HLA-DQB1, HLA-DRB1

Biological processes related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1interferon-gamma-mediated signaling pathwayGO:006033310.1HLA-DQB1, HLA-DRB1
2positive regulation of phosphorylationGO:00423279.3EGFR, IFNA2

Molecular functions related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426059.7HLA-DQB1, HLA-DRB1

Sources for Recurrent Respiratory Papillomatosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet